Appl Environ Microbiol., v. 68, p. 5459-5463, 2002.
38. REED B.D. Risk factors for Candida vulvovaginitis. Obstet Gynecol Surv v. 47,
p. 551-60,1992.
39. RINGDAHL, E.N. Treatment of recurrent vulvovaginal candidiasis. Am Farm
Physician., v. 61, n. 11, p. 3306-3312, 2000.
40. ROUMEN, F.J.M.E.; APTER, D.; MULDERS, T.M.T.; DIEBEN, T.O.M. Efficacy,
tolerability and acceptability of a novel contraceptive vaginal ring releasing
etonogestrel and ethinyl oestradiol. Hum Reprod., v. 16, n. 3, p. 469-475, 2001.
41. SALVATORE, C.A. Candidiases vulvovaginal. In Lacaz, C.S. Candidiases.
São Paulo: Editora da Universidade de São Paulo, 1980.
42. SHIN, J.H.; KEE, S.J.; SHIN, M.G.; KIM, S.H.; SHIN, D.H.; LEE, S.K.; SUH,
S.P.; RYANG, D.W. Biofilm production by isolates of Candida species recovered
from nonneutropenic patiens: comparison of bloodstream isolates with isolates
from others sources. J Clin Microbiol., v. 40, n. 4, p. 1244-1256, 2002.
43. SOBEL, J.D. Vaginal infections in adult women. Med Clin North Am., v. 74, p.
1575-1602, 1990.
44. SOBEL, J.D. Candidal vulvovaginitis. Clin Obstet Gynecol., v. 36 p. 153-165,
1993.
45. SOBEL, J.D.; FARO, S.; FORCE, R.W.; FOXMAN, B.; LEDGER, W.J.;
NYIRJESY, P.R.; et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and
therapeutic considerations. Am J Obstet Gynecol., v. 178, p. 211, 1998.
46. SOBEL, J. D. ; KAPERNICK, P.S.; ZERVOS, M.; REED, B.D.; HOOTON, T.;
SOPER, D.; NYIRJESY, P.; HEINE, M.W.; WILLEMS, J.; PANZER, H.;
WITTES, H. Treatment of complicated Candida vaginitis: comparison of single
and sequential doses of fluconazole. Am J Obstet Gynecol., v. 185, n.2, p. 363-
369, 2001.